Baseline and treatment characteristics of patients with-versus-without near-complete reperfusion (eTICI 2c–3)
| Variable | Near-Complete Reperfusion (n = 186) | No Near-Complete Reperfusion (n = 224) | P Value |
|---|---|---|---|
| Age (median) (IQR) (yr) | 71.1 (61.2–80.1), n = 186 | 69.3 (58.4–79.6), n = 224 | .12 |
| Baseline NIHSS (median) (IQR) | 18 (12–21), n = 186 | 17 (13–20), n = 224 | .29 |
| History of diabetes (No.) (%) | 31/186 (16.7%) | 46/224 (20.5%) | .55 |
| History of past stroke/TIA (No.) (%) | 24/186 (12.9%) | 33/224 (14.7%) | .67 |
| History of prior cardiac disease (No.) (%) | 49/186 (26.3%) | 47/224 (21.0%) | .24 |
| Baseline ASPECTS (median) (IQR) | 8 (7–9), n = 186 | 8 (6–8), n = 224 | .13 |
| Collateral score (No.) (%) | .06 | ||
| Poor | 2/186 (1.1%) | 11/218 (5.1%) | |
| Moderate | 154/186 (82.8%) | 178/218 (81.7%) | |
| Good | 30/186 (16.1%) | 29/218 (13.3%) | |
| Study drug to reperfusion time (median) (IQR) (min) | 22 (9–39), n = 182 | 26 (12–52), n = 170 | .17 |
| Terminal ICA occlusion (No.) (%) | 28/186 (15.1%) | 44/223 (19.7%) | .24 |
| IV alteplase (No.) (%) | 110/186 (59.1%) | 122/224 (54.5%) | .37 |
| IV nerinetide (No.) (%) | 89/186 (47.9%) | 107/224 (47.8%) | 1.00 |
| Stent retriever as first-line device (No.) (%) | 150/204 (73.5) | 142/176 (80.7) | .103 |
| Carotid stent placement during EVT | 22/110 (20.0) | 12/81 (14.8) | .445 |
Note:—IQR indicates interquartile range.